Revvity Inc. (NYSE:RVTY) Given Average Rating of “Hold” by Brokerages

Shares of Revvity Inc. (NYSE:RVTY) have been given a consensus recommendation of “Hold” by the sixteen ratings firms that are covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and four have given a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $108.9167.

Several equities analysts have commented on the stock. The Goldman Sachs Group lowered their target price on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 14th. JPMorgan Chase & Co. reduced their price target on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Sanford C. Bernstein initiated coverage on shares of Revvity in a report on Friday, June 26th. They issued a “market perform” rating and a $115.00 price objective for the company. Evercore reiterated an “outperform” rating and set a $125.00 price objective on shares of Revvity in a research note on Monday, July 6th. Finally, TD Cowen reissued a “buy” rating on shares of Revvity in a report on Wednesday.

Revvity Trading Down 1.4%

NYSE:RVTY opened at $110.16 on Friday. Revvity has a 1 year low of $81.22 and a 1 year high of $118.30. The stock has a market cap of $12.29 billion, a price-to-earnings ratio of 52.71, a PEG ratio of 2.17 and a beta of 1.09. The business has a fifty day moving average of $103.56 and a 200-day moving average of $99.15. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. The company had revenue of $711.12 million for the quarter, compared to analyst estimates of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The company’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period last year, the company earned $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities analysts predict that Revvity will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be given a dividend of $0.07 per share. The ex-dividend date is Friday, July 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s dividend payout ratio (DPR) is 13.40%.

Institutional Trading of Revvity

Institutional investors have recently modified their holdings of the company. Tudor Investment Corp ET AL acquired a new stake in Revvity during the third quarter valued at approximately $15,128,000. JPMorgan Chase & Co. grew its position in Revvity by 15.2% in the third quarter. JPMorgan Chase & Co. now owns 511,360 shares of the company’s stock worth $44,821,000 after buying an additional 67,662 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Revvity by 127.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock valued at $171,921,000 after buying an additional 980,142 shares in the last quarter. SG Americas Securities LLC increased its holdings in shares of Revvity by 186.8% in the fourth quarter. SG Americas Securities LLC now owns 123,173 shares of the company’s stock valued at $11,917,000 after buying an additional 80,226 shares in the last quarter. Finally, KBC Group NV lifted its position in shares of Revvity by 115.4% during the 4th quarter. KBC Group NV now owns 39,522 shares of the company’s stock valued at $3,824,000 after acquiring an additional 21,174 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.